Platelet-rich plasma for treatment of chronic proximal hamstring tendinopathy

To determine whether platelet-rich plasma (PRP) can successfully treat symptoms associated with proximal hamstring tendinopathy. Charts were retrospectively reviewed of patients with a diagnosis of chronic proximal hamstring tendinopathy who underwent an ultrasound-guided leukocyte-rich PRP injectio...

Full description

Saved in:
Bibliographic Details
Published in:Regenerative medicine 2020-04, Vol.15 (4), p.1509-1518
Main Authors: Auriemma, Michael J, Tenforde, Adam S, Harris, Adam, McInnis, Kelly C
Format: Article
Language:English
Subjects:
Age
Blood
Blood platelets
cell therapy
Exercise
growth factors
Pain
Patients
Physical fitness
regeneration
repair
Studies
Tendons
Track & field
translational studies
Ultrasonic imaging
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To determine whether platelet-rich plasma (PRP) can successfully treat symptoms associated with proximal hamstring tendinopathy. Charts were retrospectively reviewed of patients with a diagnosis of chronic proximal hamstring tendinopathy who underwent an ultrasound-guided leukocyte-rich PRP injection to assess reported outcomes at baseline and final follow-up post-intervention. In 22 patients with a mean age of 48.7 years and mean symptom duration of 26.5 months, mean Numeric Pain Rating Scale and Victorian Institute of Sport Assessment Scale for Proximal Hamstring Tendinopathy subscores demonstrated statistically significant improvements (p < 0.05) at a mean of 7.91 months follow-up. Sixty-eight percent of patients demonstrated ≥50% reduction of pain. Pain and functional outcomes improved following injection of PRP.
ISSN:1746-0751
1746-076X
DOI:10.2217/rme-2019-0105